Kim DDH. Tyrosine kinase inhibitors for the frontline management of CML: an overview. Can Hematol Today [Internet]. 2023 Mar. 1 [cited 2024 Nov. 23];2(1):22–26. Available from: https://canadianhematologytoday.com/article/view/2-1-4-kim